The Medicines Company Business Finance Contracts & Agreements

51 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture to 3.50% Convertible Senior Notes Due 2024 between The Medicines Company and Wells Fargo Bank, N.A.
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2020
First Supplemental Indenture to 2.75% Convertible Senior Notes Due 2023 between The Medicines Company and Wells Fargo Bank, N.A.
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2020
First Supplemental Indenture to 2.50% Convertible Senior Notes Due 2022 – The Medicines Company and Wells Fargo Bank, N.A.
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2020
Underwriting Agreement, dated as of June 25, 2019, by and among the Company, Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC
Underwriting Agreements
The Medicines Company
Pharmaceuticals
NY
2019
Indenture Agreement for 3.50% Convertible Senior Notes due 2024 between The Medicines Company and Wells Fargo Bank, N.A.
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2018
The Medicines Company Non-Statutory Stock Option Agreement under 2013 Stock Incentive Plan
Stock Agreements
The Medicines Company
Pharmaceuticals
2018
Amendment to Employment Agreement between The Medicines Company and Clive Meanwell (November 14, 2017)
Modification Agreements
The Medicines Company
Pharmaceuticals
2018
Purchase and Sale Agreement between The Medicines Company and Melinta Therapeutics, Inc. (November 28, 2017)
Purchase Agreements
The Medicines Company
Pharmaceuticals
DE
2017
Second Amendment to Contract Manufacturing Agreement between Fresenius Kabi USA, LLC and The Medicines Company
Modification Agreements
The Medicines Company
Pharmaceuticals
2017
Call Option Confirmation Agreement between Goldman, Sachs & Co. and The Medicines Company (June 7, 2016)
Warrant Agreements
The Medicines Company
Pharmaceuticals
NY
2016
Base Call Option Transaction Confirmation between Goldman, Sachs & Co. and The Medicines Company (June 2016)
Warrant Agreements
The Medicines Company
Pharmaceuticals
NY
2016
Indenture for 2.75% Convertible Senior Notes due 2023 between The Medicines Company and Wells Fargo Bank, N.A.
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2016
Purchase and Sale Agreement among The Medicines Company, Chiesi Farmaceutici S.p.A., and Chiesi USA, Inc. (May 9, 2016)
Purchase Agreements
The Medicines Company
Pharmaceuticals
DE
2016
Amendment to Contract Manufacturing Agreement between Fresenius Kabi USA, LLC and The Medicines Company
Modification Agreements
The Medicines Company
Pharmaceuticals
2016
Purchase and Sale Agreement between The Medicines Company and Mallinckrodt Entities (December 18, 2015)
Purchase Agreements
The Medicines Company
Pharmaceuticals
NY
2016
Investment Agreement between Eshelman Ventures, LLC and The Medicines Company (August 25, 2015)
Investment Agreements
The Medicines Company
Pharmaceuticals
NY
2015
Indenture for 2.50% Convertible Senior Notes due 2022 between The Medicines Company and Wells Fargo Bank, N.A.
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2015
Underwriting Agreement for Sale of Common Stock by The Medicines Company to J.P. Morgan Securities LLC and Merrill Lynch
Underwriting Agreements
The Medicines Company
Pharmaceuticals
NY
2013
The Medicines Company Restricted Stock Agreement Under 2013 Stock Incentive Plan
Equity Distribution Agreements
The Medicines Company
Pharmaceuticals
DE
2013
The Medicines Company Restricted Stock Agreement under 2013 Stock Incentive Plan
Equity Distribution Agreements
The Medicines Company
Pharmaceuticals
DE
2013
Non-Statutory Stock Option Agreement under The Medicines Company 2013 Stock Incentive Plan
Warrant Agreements
The Medicines Company
Pharmaceuticals
2013
The Medicines Company Non-Statutory Stock Option Agreement under 2013 Stock Incentive Plan
Warrant Agreements
The Medicines Company
Pharmaceuticals
2013
Share Purchase Agreement among The Medicines Company, ProFibrix B.V., Equityholders, Warrantors, Option Holders, and Stichting ProFibrix Sellers Representative (June 4, 2013)
Purchase Agreements
The Medicines Company
Pharmaceuticals
DE
2013
Amendment and Settlement Agreement to License Agreement between Biogen Idec MA Inc. and The Medicines Company (August 7, 2012)
Modification Agreements
The Medicines Company
Pharmaceuticals
2012
Indenture for 1.375% Convertible Senior Notes due 2017 between The Medicines Company and Wells Fargo Bank, N.A.
Indenture Agreements
The Medicines Company
Pharmaceuticals
NY
2012
Manufacturing Services Agreement between Patheon International A.G. and The Medicines Company (MDCO) dated March 30, 2011
Exchange Agreements
The Medicines Company
Pharmaceuticals
NJ
2011
Restricted Stock Agreement between The Medicines Company and Clive A. Meanwell under 2004 Stock Incentive Plan
Stock Agreements
The Medicines Company
Pharmaceuticals
DE
2011
The Medicines Company Restricted Stock Agreement under 2004 Stock Incentive Plan
Stock Agreements
The Medicines Company
Pharmaceuticals
DE
2010
Consent and Release Agreement among The Medicines Company, Washington Cardiovascular Associates, HDLT LLC, and Individuals Regarding Pfizer License
Release Agreements
The Medicines Company
Pharmaceuticals
NY
2010
Amendment to Sale and Purchase Agreement between Curacyte AG, The Medicines Company (Leipzig) GmbH, and The Medicines Company
Purchase Agreements
The Medicines Company
Pharmaceuticals
2010
The Medicines Company Restricted Stock Agreement under 2009 Equity Inducement Plan
Stock Agreements
The Medicines Company
Pharmaceuticals
DE
2009
The Medicines Company Non-Statutory Stock Option Agreement for Italian Employees under 2009 Equity Inducement Plan
Stock Agreements
The Medicines Company
Pharmaceuticals
2009
The Medicines Company Non-Statutory Stock Option Agreement under 2009 Equity Inducement Plan
Stock Agreements
The Medicines Company
Pharmaceuticals
2009
Sale and Purchase Agreement for All Shares in Curacyte Discovery GmbH Between Curacyte AG and Lilie 39. V V GmbH (MDCO Acquisition GmbH), with TMC Guarantee
Purchase Agreements
The Medicines Company
Pharmaceuticals
NY
2008
The Medicines Company Restricted Stock Agreement Under 2007 Equity Inducement Plan
Stock Agreements
The Medicines Company
Pharmaceuticals
DE
2008
Non-Statutory Stock Option Agreement under 2007 Equity Inducement Plan between The Medicines Company and Employee
Warrant Agreements
The Medicines Company
Pharmaceuticals
2008
The Medicines Company Restricted Stock Agreement Under 2004 Stock Incentive Plan
Stock Agreements
The Medicines Company
Pharmaceuticals
DE
2006
Stock Option Vesting Acceleration and Lock-Up Agreement between The Medicines Company and Option Holder (December 23, 2005)
Equity Distribution Agreements
The Medicines Company
Pharmaceuticals
2006
Nonstatutory Stock Option Agreement under 2004 Stock Incentive Plan – The Medicines Company and Participant
Stock Agreements
The Medicines Company
Pharmaceuticals
2005
Nonstatutory Stock Option Agreement between The Medicines Company and Participant under 1998 Stock Incentive Plan
Stock Agreements
The Medicines Company
Pharmaceuticals
2004